MG
GMED icon

Mather Group’s Globus Medical GMED Stock Holding History

Mather Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.6K Sell
299
-6
-2% -$510 ﹤0.01% 1290
2026
Q1 		$26.3K Buy
+305
New +$27.4K ﹤0.01% 1217
2025
Q4 		– Sell
-395
Closed -$22.6K – 1041
2025
Q3 		$22.6K Buy
+395
New +$22.7K ﹤0.01% 1091
2025
Q2 		– Sell
-1,417
Closed -$104K – 1051
2025
Q1 		$104K Buy
1,417
+61
+4% +$5.04K ﹤0.01% 740
2024
Q4 		$112K Buy
1,356
+190
+16% +$15K ﹤0.01% 711
2024
Q3 		$83.4K Sell
1,166
-165
-12% -$11.6K ﹤0.01% 776
2024
Q2 		$71.4K Buy
1,331
+34
+3% +$2.03K ﹤0.01% 908
2024
Q1 		$69.1K Buy
+1,297
New +$69.7K ﹤0.01% 802

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Mather Group's GMED Position: Q2 2026 in Review

Mather Group reduced its Globus Medical (GMED) stake by 2% in Q2 2026, selling an estimated $510 and leaving 299 shares worth $23.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

Mather Group first reported a position in GMED in Q1 2024 and has held it in 8 quarters since. The position peaked at $112K in Q4 2024. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Mather Group held 299 shares of Globus Medical worth $23.6K as of Q2 2026.
  • Mather Group sold 6 Globus Medical shares in Q2 2026, an estimated $510.
  • Globus Medical made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1290 holding.
  • Mather Group first reported a position in Globus Medical in Q1 2024 and has held it in 8 quarters since.
  • Mather Group's Globus Medical position peaked at $112K in Q4 2024.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.